Tag: the war on (some) drugs

Rhode Island Lawmakers Approve Psilocybin Legalization Bill

A Rhode Island legislative committee this week approved a bill to legalize the possession and cultivation of psilocybin mushrooms, making the state the latest of several to propose or advance legislation to ease the prohibitions on magic mushrooms and other psychedelic drugs. The measure, House Bill 5923, was approved by the House Judiciary Committee by a 12-2 vote on Tuesday, according to a report from Marijuana Moment. A companion bill is pending in the Rhode Island Senate, where the chamber’s Judiciary Committee is holding the bill for further study.

If passed, the legislation would eliminate criminal penalties for adults who possess or cultivate up to one ounce of psilocybin mushrooms for personal use. Up to one ounce of mushrooms could also be shared by one adult with another. The bill is slated to go into effect on July 1, and an amendment approved by the Judiciary Committee sets a July 1, 2025, sunset for the legislation.

Keep reading

Healing brain trauma with psychedelics

Ian McCall is a former professional Mixed Martial Arts (MMA) fighter who suffered from symptoms of traumatic brain injuries. After retirement, McCall experienced confusion, anger issues, depression, addiction and suicidal ideation. He tried brain stimulation therapy, but that did not work. So, he turned to a less traditional form of therapy: psilocybin mushrooms.

“I am a very loving, happy person, and I wasn’t for a large portion of my life. Because I was just tortured. I was tortured, and then I was confused, and I was addicted, and I was just crazy for a long time,” McCall said.

Psilocybin mushrooms, also known as magic mushrooms or shrooms, are naturally occurring psychedelics that can affect all senses. They can alter a person’s way of thinking and can cause hallucinations.

“The most important thing to know is that if you take psilocybin or LSD, they’re incredibly safe from a physiological standpoint. You can’t really overdose on them,” Dr. Daniel F. Kelly, a practicing neurosurgeon in Santa Monica said. “They don’t create an addictive behavior like say opiates or alcohol do or nicotine. And in fact, as you probably know, they’re used to break addiction.”

Keep reading

Hallucinogen use is on the rise among young adults

A significant upsurge in the usage of non-LSD hallucinogens among young adults in the United States is causing concern among researchers. An insightful study conducted by the University of Michigan and Columbia University reveals that in the period between 2018 and 2021, the use of these drugs by individuals aged 19 to 30 almost doubled.

Back in 2018, it was found that 3.4% of young adults reported having used non-LSD hallucinogens in the past year. This figure spiked to 6.6% in 2021. 

Sudden surge is surprising

While this prevalence remains relatively low compared to substance usage like alcohol and cannabis, this sudden surge over a mere three years presents potential public health worries.

“The increase in non-LSD hallucinogen use occurred while LSD use remained stable at around 4% in 2018 and 2021,” stated Megan Patrick, a research professor in the Survey Research Center at U-M’s Institute for Social Research. 

Patrick, who is a co-author of the study, emphasized that the leap in prevalence is substantial and raises critical health-related concerns.

How the study was conducted

This noteworthy information was uncovered as a part of the Monitoring the Future study, funded by the National Institute on Drug Abuse, and the results were published in the journal Addiction. 

The study, involving a longitudinal follow-up of 12th-grade students transitioning into adulthood, focused primarily on substance use and health.

In addition to the overall increase in hallucinogen usage, the research team discovered that the consumption of these substances was notably higher among males compared to females. 

Additionally, white young adults reported higher usage rates than Black young adults, and those whose parents possessed a college education, indicating a higher socioeconomic status, were also found to use these substances more frequently.

While the reasons behind the usage of these drugs, whether recreational or therapeutic, were not identified in the study, previous research has shown a link between nonmedical hallucinogen use and an increased risk of substance use disorders, self-harm, injury, and anxiety.

“With increased visibility for medical and therapeutic use, potentially comes diversion and unregulated product availability, as well as a lack of understanding among the public of potential risks,” explained Katherine Keyes, a professor of epidemiology at Columbia Mailman School and the lead author of the study.

Keep reading

These ‘Psychedelic Cryptography’ Videos Have Hidden Messages Designed to Be Seen While Tripping

A new competition focused on “Psychedelic Cryptography” has awarded cash prizes to artists who made videos encoded with hidden messages that can be most easily deciphered by a person who is tripping on psychedelic substances, such as LSD, ayahuasca, or psilocybin mushrooms.

Qualia Research Institute (QRI), a California-based nonprofit group that researches consciousness with backing from tech investors and experts, announced the winners of its Psychedelic Cryptography (PsyCrypto) contest last week. The goal of the exercise was “to create encodings of sensory information that are only meaningful when experienced on psychedelics in order to show the specific information-processing advantages of those states,” according to the original contest page, which was posted in March.

Artist Raimonds Jermaks clinched the first and second place prizes in the contest for videos entitled “Can You See Us?” and “ We Are Here. Let’s Talk.” The third prize went to Rūdolfs Balcers for the video “The Key.” The contest entries were judged by members of QRI’s international phenomenologist network, and evaluated based on their effectiveness, specificity, and aesthetic value.

The winning videos play on the common psychedelic experience of seeing radiant “tracers,” which are trails of colors and afterimages that linger in the visual field. The winning artists used this effect to write out tracer-based messages that are incomprehensible to a sober person, but that can be understood while tripping.  

Keep reading

New Study Analyzes Efficacy of Psilocybin as Treatment for Alcohol Use Disorder

A recent study published in the journal Psychology of Addictive Behaviors by the American Psychological Association on June 5 has found that psilocybin can be an effective treatment for people with alcohol addiction.

Officially entitled “Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis,” the study was conducted by researchers from New York University and University of California, San Francisco, as well as a psychedelic integration and psychedelic-assisted therapy business called Fluence.

The study objective was to “delineate psychological mechanisms of change” for those who suffer from alcohol use disorders (referred to as AUDs). All participants were engaged in interviews about their experiences, and asked questions about their alcohol use before and after the study. They were also asked about their coping patterns when enduring “strong emotions, stress, and cravings for alcohol.”

According to the study results, researchers examined how psilocybin helped them overcome various stressors. “Participants reported that the psilocybin treatment helped them process emotions related to painful past events and helped promote states of self-compassion, self-awareness, and feelings of interconnectedness,” researchers stated. “The acute states during the psilocybin sessions were described as laying the foundation for developing more self-compassionate regulation of negative affect. Participants also described newfound feelings of belonging and an improved quality of relationships following the treatment.”

Through this evidence, they explained that psilocybin “increases the malleability of self-related processing, and diminishes shame-based and self-critical thought patterns while improving affect regulation and reducing alcohol cravings,” the authors concluded. “These findings suggest that psychosocial treatments that integrate self-compassion training with psychedelic therapy may serve as a useful tool for enhancing psychological outcomes in the treatment of AUD.”

Keep reading

NY farmers with 300K pounds of weed fume over state’s slow shop roll-out

New York’s weed farmers are fuming over the snail’s-pace rollout of legal cannabis shops in the Empire State — complaining they are sitting on mountains of spoiling marijuana crops.

The state’s failure to follow through on OK’ing dozens of dispensaries for legal marijuana as predicted by Gov. Kathy Hochul last year has thwarted the roughly 200 New York farmers who grew 300,000 pounds of cannabis — the equivalent of more than 272 million half-gram joints.

The farmers say their product, most of which is eventually converted into CDB oil, has been going nowhere fast, worrying them that it could soon become too old to peddle.

And this season’s new crop is already on the horizon.

“We’re really under the gun here,” New York marijuana farmer Seth Jacobs told The Associated Press. “We’re all losing money. Even the most entrepreneurial and ambitious among us just can’t move much product in this environment.”

Keep reading

Magic mushrooms go mainstream in Colorado

Fungi are ready for their close-up.

Driving the news: After Coloradans voted to legalize psilocybin in 2022, “magic mushrooms” are now becoming more mainstream, with a first-of-its-kind study and a national psychedelic conference on the horizon.

State of play: The University of Colorado Anschutz Medical Campus in Aurora this month announced it would launch the first modern-era psilocybin clinical trial for depression this fall.

Details: The hospital is working with the Food and Drug Administration on the study, though the federal government classifies psilocybin mushrooms as a Schedule 1 narcotic.

  • It’s grouped with the most serious category of illicit drugs, including heroin and cocaine.

The intrigue: Gov. Jared Polis last week signed a bill implementing Proposition 122, which allows people 21 and older to grow and share magic mushrooms.

  • The bill also creates a regulated therapy system for medicinal use — establishing “healing centers” for people to use psilocybin under supervision — and removes criminal penalties for personal possession.

Keep reading

Kentucky’s Risky Million-Dollar Bet to Fight the Opioid Crisis With Psychedelics

On the steps of the state capitol building in Frankfort on May 31, the Kentucky Opioid Abatement Advisory Commission (KYOAAC) announced the launch of a new state-funded program that would aim to help stem the damage and destruction wrought by the ongoing opioid crisis that has devastated the lives of millions and led to the deaths of hundreds of thousands. But the new initiative wasn’t simply to throw more money and resources into tried-and-true public health programs.

Instead, the commission announced it was going to explore allocating tens of millions of dollars toward studying and promoting the use of the controversial, plant-based hallucinogen ibogaine in psychedelic-assisted therapy to combat the opioid crisis, as well as treat a host of other mental health issues. The goal is to make Kentucky the first state in the nation to pursue a clinical program around ibogaine—currently legal only in Mexico and New Zealand.

“This administration recognizes that the opioid epidemic is one of the most tragic and visible symptoms of spiritual affliction which pervades our society,” Bryan Hubbard, chairman and executive director of KYOCC, told The Daily Beast. “We must do better. We must explore every possible avenue which holds the potential for improvement.”

The news was lauded by advocates of psychedelic-assisted therapy, an increasingly popular form of mental health treatment.

“With yesterday’s announcement, Kentucky is taking a bold leadership role to addressing the opioid epidemic,” Jesse MacLachalan, state policy and advocacy coordinator for Reason For Hope, a psychedelic therapy advocacy nonprofit, told The Daily Beast. “This is a prudent and measured approach to explore innovative solutions to the greatest addiction crisis our country has experienced in its history. We applaud the Bluegrass State for the example they are setting for states across the country.”

Keep reading

Hunter Biden, Second Amendment Warrior?

President Joe Biden has long been an advocate for strict restrictions on guns, so his son makes something of an unlikely advocate for expanded gun rights. But Hunter Biden may soon find himself on the opposite side of his father’s gun control crusade in at least one aspect. The younger Biden is reportedly considering a challenge to a federal law that bans illegal drug users from owning guns.

The issue hits close to home for Hunter: The Department of Justice is investigating a gun purchase he made in 2018. This is a time period during which he has admitted to regularly using crack cocaine. That could put him afoul of the law against drug users having guns.

Hunter Biden’s “lawyers have already told Justice Department officials that, if their client is charged with the gun crime, they will challenge the law under the Second Amendment, according to a person familiar with the private discussions granted anonymity because they are not authorized to speak publicly,” reported Politico. “That could turn a case that is already fraught with political consequences into a high-profile showdown over the right to bear arms.”

Here’s hoping?

The provision in question—part of the Gun Control Act of 1968—is, frankly, insane, preventing any person “who is an unlawful user of or addicted to any controlled substance” from buying a gun. The Bureau of Alcohol, Tobacco, and Firearms has interpreted this provision to mean that anyone who has used any illegal drug in the past 12 months cannot legally purchase a gun.

And the time may be just right for challenging it. This Supreme Court has proved willing to strike down overreaching gun laws.

Keep reading

ATF: Marijuana users in Minnesota can’t own firearms despite new law

Just one day after Minnesota legalized the recreational use of marijuana, an agency that regulates the use of firearms warned that any current user of marijuana is prohibited from possessing firearms or ammunition.  

The Bureau of Alcohol, Tobacco, Firearms and Explosives (AFT) field office in St. Paul, Minn., issued the clarification Tuesday shortly after Gov. Tim Walz (D) signed a bill legalizing recreational marijuana. The clarification states that under federal law, current users of marijuana are prohibited from possessing, receiving, transporting or shipping firearms or ammunition.  

“Until marijuana is legalized federally, firearms owners and possessors should be mindful that it remains federally illegal to mix marijuana with firearms and ammunition,” Jeff Reed, ATF’s acting special agent in charge of the St. Paul Field Division, said in a statement.

“As regulators of the firearms industry and enforcers of firearms laws, we felt it was important to remind Minnesotans of this distinction as the marijuana laws adjust here in the State of Minnesota.” 

According to an analysis by the RAND Corporation, nearly 40 percent of residents in Minnesota reported owning a gun between 2007 and 2016. According to the Centers for Disease Control and Prevention, about 18 percent of Americans reported using marijuana in 2019.

Keep reading